Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001171843-14-004353)

Filing Details

Accession Number:: 0001171843-14-004353
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-09-15 18:53:28
Reporting Period:: 2014-09-12

Filing Date:: 2014-09-15
Accepted Time:: 2014-09-15 17:53:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
3116	Akorn Inc	AKRX	Pharmaceutical Preparations (2834)	720717400

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1467848	Brian Tambi	1925 West Field Court Suite 300 Lake Forest IL 60045		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-09-12	20,000	$0.94	48,591	No	4	M	Direct
Common Stock	Disposition	2014-09-12	13,800	$38.00	34,791	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2014-09-12	20,000	$0.00	20,000	$0.94

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2009-06-22	2019-06-22	No	4	M	Direct

Footnotes

Proceeds from the sale were used to pay exercise price and taxes due upon exercise of options.
Amount of Shares Beneficially Owned Following Reported Transaction includes 8,034 unvested shares subject to restricted stock awards and 26,757 shares owned outright.
There was no consideration given in exchange for the security.